Home
/
CONMED Corp
/
Financials
/
Quarterly
CONMED Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CONMED Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$337.93M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$342.35M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$321.26M
May 1, 2025
Q3
2025
Sep 30, 2024
$316.70M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$332.10M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$312.27M
May 1, 2025
Q3
2024
Sep 30, 2023
$304.58M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$317.65M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$295.47M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$275.09M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$277.19M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$242.33M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$248.83M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$255.16M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$232.68M
May 5, 2022
Q3
2021
Sep 30, 2020
$237.84M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$157.79M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$214.01M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$233.59M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$238.26M
Jul 30, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$337.93M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$342.35M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$321.26M
May 1, 2025
Q3
2025
Sep 30, 2024
$316.70M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$332.10M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$312.27M
May 1, 2025
Q3
2024
Sep 30, 2023
$304.58M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$317.65M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$295.47M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$275.09M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$277.19M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$242.33M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$248.83M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$255.16M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$232.68M
May 5, 2022
Q3
2021
Sep 30, 2020
$237.84M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$157.79M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$214.01M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$233.59M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$238.26M
Jul 30, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$212.82M
Aug 2, 2018
Q1
2018
Mar 31, 2018
$202.06M
Apr 26, 2018
Q3
2017
Sep 30, 2017
$190.12M
Nov 2, 2017
Q2
2018
Jun 30, 2017
$197.15M
Aug 2, 2018
Q1
2018
Mar 31, 2017
$186.57M
Apr 26, 2018
Q3
2017
Sep 30, 2016
$184.79M
Nov 2, 2017
Q2
2017
Jun 30, 2016
$193.43M
Jul 27, 2017
Q1
2017
Mar 31, 2016
$181.20M
Apr 27, 2017
Q3
2016
Sep 30, 2015
$169.18M
Oct 28, 2016
Q2
2016
Jun 30, 2015
$181.03M
Jul 28, 2016
Q1
2016
Mar 31, 2015
$177.94M
May 2, 2016
Q3
2015
Sep 30, 2014
$174.96M
Oct 23, 2015
Q2
2015
Jun 30, 2014
$188.15M
Jul 27, 2015
Q1
2015
Mar 31, 2014
$181.94M
Apr 24, 2015
Q3
2014
Sep 30, 2013
$179.26M
Oct 24, 2014
Q2
2014
Jun 30, 2013
$192.99M
Jul 25, 2014
Q1
2014
Mar 31, 2013
$187.01M
Apr 25, 2014
Q3
2013
Sep 30, 2012
$181.89M
Oct 28, 2013
Q2
2013
Jun 30, 2012
$189.70M
Jul 29, 2013
Q1
2013
Mar 31, 2012
$194.32M
Apr 29, 2013
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.86M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$21.42M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$6.04M
May 1, 2025
Q3
2025
Sep 30, 2024
$48.98M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$29.98M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$19.71M
May 1, 2025
Q3
2024
Sep 30, 2023
$15.84M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$13.73M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$1.82M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$46.15M
Oct 26, 2023
Q2
2023
Jun 30, 2022
($168.29M)
Jul 27, 2023
Q1
2023
Mar 31, 2022
$14.98M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$14.95M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$13.29M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$9.86M
May 5, 2022
Q3
2021
Sep 30, 2020
$6.85M
Oct 28, 2021
Q2
2021
Jun 30, 2020
($27.40M)
Jul 29, 2021
Q1
2021
Mar 31, 2020
$5.93M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$6.97M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$5.70M
Jul 30, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$11.88M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$38.16M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$15.96M
May 1, 2025
Q3
2025
Sep 30, 2024
$65.71M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$47.11M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$35.01M
May 1, 2025
Q3
2024
Sep 30, 2023
$30.30M
Oct 31, 2024
Q2
2024
Jun 30, 2023
$27.42M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$12.70M
Apr 25, 2024
Q3
2023
Sep 30, 2022
$24.25M
Oct 26, 2023
Q2
2023
Jun 30, 2022
$24.46M
Jul 27, 2023
Q1
2023
Mar 31, 2022
$22.44M
Apr 27, 2023
Q3
2022
Sep 30, 2021
$26.71M
Oct 27, 2022
Q2
2022
Jun 30, 2021
$25.71M
Jul 28, 2022
Q1
2022
Mar 31, 2021
$20.08M
May 5, 2022
Q3
2021
Sep 30, 2020
$29.38M
Oct 28, 2021
Q2
2021
Jun 30, 2020
($21.25M)
Jul 29, 2021
Q1
2021
Mar 31, 2020
$13.17M
Apr 29, 2021
Q3
2020
Sep 30, 2019
$20.94M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$18.66M
Jul 30, 2020